JAMA: Fish oil RCT shows some benefit in terms of AV grafts, but primary outcome was negative. PDF Print
JAMA: Conclusions Among patients with new hemodialysis grafts, daily fish oil ingestion did not decrease the proportion of grafts with loss of native patency within 12 months. Although fish oil improved some relevant secondary outcomes such as graft patency, rates of thrombosis, and interventions, other potential benefits on cardiovascular events require confirmation in future studies.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.